" class="no-js "lang="en-US"> Biogen Archives - Medtech Alert
Wednesday, December 06, 2023

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Great Britain

Eisai and Biogen announced today that Eisai has submitted a Marketing Authorization Application (MAA) for […]

Muscular Dystrophy Association Celebrates FDA Approval of Biogen’s Qalsody for Treatment of SOD1-ALS

The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) accelerated approval […]

Biologics License Application for Lecanemab Designated for Priority Review by China National Medical Products Administration

Eisai and Biogen announced today that the Biologics License Application (BLA) for lecanemab, an investigational […]

Eisai Submits Marketing Autherization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Europe

Eisai and Biogen have announced that Eisai has submitted a marketing authorization application (MAA) for […]

Ionis and Royalty Pharma Enter Into Royalty Agreement for Up to $1.1 billion

Ionis Pharmaceuticals and Royalty Pharma plc today announced that Royalty Pharma has acquired an interest […]

Samsung Biologics Reaches Agreement with Biogen to Acquire Full Ownership of Samsung Bioepis

Samsung Biologics (KRX: 207940.KS) announced today that it has reached an agreement with Biogen for the buyout […]

FDA Approval of Aducanumab

Neurimmune welcomes the news that the U.S. Food and Drug Administration (FDA) has approved Biogen‘s […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more